MRI in the era of nephrogenic systemic fibrosis: Review, controversies and suggestions for risk reduction

Phillip H. Kuo; Ali Abu-Alfa; Richard Bucala; Jason Griffith; Kacie Carlson; Michael Girardi; Jeffrey Weinreb; Shawn Cowper

MRI in the era of nephrogenic systemic fibrosis: Review, controversies and suggestions for risk reduction

Phillip H. Kuo, Ali Abu-Alfa, Richard Bucala, Jason Griffith, Kacie Carlson, Michael Girardi, Jeffrey Weinreb, Shawn Cowper

Research output: Contribution to journal › Review article › peer-review

11 Scopus citations

Abstract

In the last 3 years, revelations linking gadolinium-based contrast agents (GBCAs) and nephrogenic systemic fibrosis (NSF) have had a tremendous impact on the utilization of enhanced magnetic resonance imaging (MRI) in patients with kidney disease. Virtually unknown to the radiology community prior to 2006, NSF has generated significant concern and confusion among radiologists, clinicians and patients.

Original language	English (US)
Pages (from-to)	22-33
Number of pages	12
Journal	Applied Radiology
Volume	38
Issue number	4
State	Published - Apr 2009

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Cite this

@article{c50261523dc5400aa5467c70cc633286,

title = "MRI in the era of nephrogenic systemic fibrosis: Review, controversies and suggestions for risk reduction",

abstract = "In the last 3 years, revelations linking gadolinium-based contrast agents (GBCAs) and nephrogenic systemic fibrosis (NSF) have had a tremendous impact on the utilization of enhanced magnetic resonance imaging (MRI) in patients with kidney disease. Virtually unknown to the radiology community prior to 2006, NSF has generated significant concern and confusion among radiologists, clinicians and patients.",

author = "Kuo, {Phillip H.} and Ali Abu-Alfa and Richard Bucala and Jason Griffith and Kacie Carlson and Michael Girardi and Jeffrey Weinreb and Shawn Cowper",

year = "2009",

month = apr,

language = "English (US)",

volume = "38",

pages = "22--33",

journal = "Applied Radiology",

issn = "0160-9963",

publisher = "Anderson Publishing Ltd",

number = "4",

}

TY - JOUR

T1 - MRI in the era of nephrogenic systemic fibrosis

T2 - Review, controversies and suggestions for risk reduction

AU - Kuo, Phillip H.

AU - Abu-Alfa, Ali

AU - Bucala, Richard

AU - Griffith, Jason

AU - Carlson, Kacie

AU - Girardi, Michael

AU - Weinreb, Jeffrey

AU - Cowper, Shawn

PY - 2009/4

Y1 - 2009/4

N2 - In the last 3 years, revelations linking gadolinium-based contrast agents (GBCAs) and nephrogenic systemic fibrosis (NSF) have had a tremendous impact on the utilization of enhanced magnetic resonance imaging (MRI) in patients with kidney disease. Virtually unknown to the radiology community prior to 2006, NSF has generated significant concern and confusion among radiologists, clinicians and patients.

AB - In the last 3 years, revelations linking gadolinium-based contrast agents (GBCAs) and nephrogenic systemic fibrosis (NSF) have had a tremendous impact on the utilization of enhanced magnetic resonance imaging (MRI) in patients with kidney disease. Virtually unknown to the radiology community prior to 2006, NSF has generated significant concern and confusion among radiologists, clinicians and patients.

UR - http://www.scopus.com/inward/record.url?scp=65249160161&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65249160161&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:65249160161

SN - 0160-9963

VL - 38

SP - 22

EP - 33

JO - Applied Radiology

JF - Applied Radiology

IS - 4

ER -

MRI in the era of nephrogenic systemic fibrosis: Review, controversies and suggestions for risk reduction

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this